Research report
Prevalence of seasonal affective disorder in primary care; a comparison of the seasonal health questionnaire and the seasonal pattern assessment questionnaire

https://doi.org/10.1016/S0165-0327(02)00314-2Get rights and content

Abstract

Background: Prevalence rates of SAD suggested by previous studies have ranged from 1 to 12% depending on the diagnostic criteria used. The Seasonal Pattern Assessment Questionnaire (SPAQ), a widely used screening tool, has been shown to have low specificity for SAD. The Seasonal Health Questionnaire (SHQ) was designed to better reflect the clinical criteria for SAD and has been shown to have a higher specificity then the SPAQ in a psychiatric outpatient setting. Objective: The current study was designed to assess the validity of the SHQ in general practice against systematic research interviews, to compare the sensitivity, specificity and positive predictive values of the SHQ and the SPAQ and to use these data to estimate the prevalence of SAD in primary care. Methods: 809 subjects in a consecutive series of patients attending Southampton general practices in winter 2000/01 completed the SHQ followed by the SPAQ; 56 were interviewed using the Structured Clinical Interview for DSM (SCID). Results: The SHQ was more sensitive and specific than the SPAQ and had higher positive and negative predictive values in screening for SAD. The SPAQ indicated a prevalence of SAD of 10.7% (95% CI 8.6–13.1) while the SHQ provided a significantly lower estimate of 5.6% (95% CI 4.2–7.4).

Introduction

Seasonal affective disorder (SAD) is a condition where sufferers experience recurrent depressive episodes during the same season of the year (Rosenthal et al., 1984). The condition is likely to be the extreme end of the dimension of seasonality, i.e. the extent to which one is affected by the change in seasons (Thompson et al., 1988). Thus, for example in Montgomery County, USA, a telephone survey showed that 92% of the population reported some seasonal changes in mood (Kasper et al., 1989) making the definition of a threshold for clinical SAD a more than trivial task.

Although SAD is most typically characterised by the reversed vegetative shift of hypersomnia, hyperphagia and weight gain (Garvey et al., 1988), these symptoms do not appear in the DSM IV or ICD criteria, which require only seasonal recurrences of major depressive disorder, whether or not they have atypical symptoms. Thus there are two models of SAD, the seasonality dimension model, which requires only a score above threshold on a rating scale, and the diagnostic model, which requires clear cut episodes of mood disorder. The fact that atypical symptoms are common in nonseasonal depression and that assessing the periodicity of episodes is not straightforward means that separating SAD from nonseasonal recurrent depression is also a more than trivial task.

Nevertheless, the apparently selective response of SAD and sub-syndromal SAD to bright light therapy (Thompson, 2001, Partonen and Lönnqvist, 2000) indicates the need for diagnosis especially in primary care where most such patients will be found.

Perhaps partly for these reasons the prevalence of SAD remains unclear, with general population estimates ranging from 0.4 to 12% (Blazer et al., 1998, Dam et al., 1998). The gender ratio is also unclear, most studies showing an excess in women (Schlager et al., 1993) but one giving an excess in men (Blazer et al., 1998). Onset appears to be usually in the third decade (Rodin and Thompson, 1997) but it can rarely occur among children (Sourander et al., 1999) and the elderly (Michalak, 2000). There appears to be a relationship to latitude (Mersch et al., 1999), but this is not invariable as the prevalence in Iceland is surprisingly low (Magnússon and Stefánsson, 1993).

There are several reasons why prevalence studies may have given widely dispersed estimates. The first is that the illness can only be observed in one season and the prevalence may differ according to geographical location. Second, most studies suffer from recall bias as shown by the lower prevalence in prospective than retrospective studies (Nayyar and Cochrane, 1996). Thirdly, there are four different definitions of SAD in use, in addition to the threshold definition on the SPAQ; the original Rosenthal criteria (Rosenthal et al., 1984), DSM-III-R (APA, 1987), DSM-IV (APA, 1994) and ICD-10 (World Health Organisation, 1992). All of these are complex definitions, requiring a diagnosis of depression in each of the episodes and an assumption that all counted episodes were similar. A minimum number of the episodes must have occurred in the same season of the year (which must itself be defined). The Rosenthal, DSM IV and ICD-10 criteria only require two but the DSM III-R requires three episodes. The number of previous years during which the episodes took place is not defined in the criteria but often assumed to be the whole lifetime. The maximum number of allowed episodes of nonseasonal depression, and the ratio to seasonal episodes must be defined to demonstrate seasonality (Thompson and Cowan, 2001). The Rosenthal criteria allow no nonseasonal episodes, DSM IIR requires a ratio greater than 3:1, while DSM IV and ICD-10 leave it to clinical intuition.

These intrinsic difficulties in the epidemiology of SAD are further complicated by the differences in item content between the clinical criteria and the most commonly used screening tool (the SPAQ; Rosenthal et al., 1984) which asks about seasonal variation in sleep, socialising, mood, appetite, weight and energy level. A seasonality score of 11 and a global severity assessment of moderate is taken to indicate SAD (Kasper et al., 1989). This model, however, corresponds to the dimensional concept of SAD rather than the diagnostic one. The difference may explain the low specificity of the SPAQ (Raheja et al., 1996, Eagles et al., 1999) its poor discrimination between SAD, and other forms of depression, and its low positive predictive value (45–48%: Magnússon, 1996, Raheja et al., 1996). It also has poor test–retest reliability, and is a poor predictor of future seasonal episodes (Raheja et al., 1996).

We have previously described the development of the Seasonal Health Questionnaire (Thompson and Cowan, 2001) as an alternative approach to screening based on the diagnostic rather than the dimensional concept. It is a machine-readable form that has been structured to identify patients with SAD according to each of the four definitions. Unlike the SPAQ, it limits the time frame to the past decade. It begins by screening for depression and then explores the relationship between depressive episodes and the seasons. The structured of the questionnaire enables the patient to stop as soon as they fail to meet one of the obligatory criteria. Patients with a seasonal pattern who do not meet criteria for major depressive episode are categorised as sub-syndromal, as described in the DSM IV textual accompaniment to the criteria (p. 389).

In a previous study the SHQ and the SPAQ were compared in a small group of clinically diagnosed out patients with either SAD or nonseasonal major depressive disorder, and the SPAQ was shown to be a more sensitive but less specific screening tool (Thompson and Cowan, 2001).

  • 1.

    To assess the positive and negative predictive value of the SHQ and SPAQ against a structured research diagnostic interview (SCID).

  • 2.

    To estimate the prevalence of SAD in consecutive primary care attendees in Southampton.

Section snippets

Pilot

The SHQ was modified by the removal of questions relating to the Rosenthal criteria which had been found to be the least specific for SAD, the other three diagnostic groups being highly congruent. The machine-readable forms and the corresponding spss program were altered to take account of these changes. The revised questionnaire was then given to 15 unselected patients in one primary care practice. Patients were asked to read through the whole form and comment on the clarity of the questions.

Patient characteristics

A total of 803 subjects filled in the SHQ (77.6% response), 749 (72.9% response) of whom also completed the SPAQ. The age range was 26–97 years (mean 47) and the female-to-male ratio was 2:1. Of the subjects 53% gave consent for a later interview.

Rates of SAD and depression according to SHQ and SPAQ

The prevalence of SAD was estimated to be significantly lower using the SHQ (5.6% CI 4.2–7.4) than the SPAQ (10.7% CI 8.7–13.1). In addition, there were fewer borderline results with the SHQ, only 0.4% of subjects being given a S-SAD result on the SHQ

Discussion

Our results indicate that the SHQ is a more valid tool on all measures than the SPAQ when screening for SAD in primary care. The finding of greater sensitivity and specificity is an unusual result when comparing psychiatric screening tools, where one tends to trade off against the other. The SPAQ labelled almost twice as many subjects as having SAD than the SHQ. The greater sensitivity and specificity enabled the SHQ to place borderline patients into normal or SAD categories, giving only 0.4%

Conclusion

The SHQ is a valid tool for GPs to use in screening for SAD and for identifying patients who may benefit from bright light therapy. We estimate the prevalence of SAD in primary care to be about 5.6%.

References (23)

  • M.J. Garvey et al.

    Comparison of Seasonal and nonseasonal affective disorders

    Am. J. Psychiatry

    (1988)
  • Cited by (37)

    • Eye disorder differentiates seasonality outcomes in persons with severe visual impairment

      2017, Journal of Affective Disorders
      Citation Excerpt :

      SAD is highly prevalent in countries with large seasonal variation in photoperiod where prevalence rates as high as 8–12% are reported in northern parts of the United States and Scandinavia when applying the frequently used screening tool, the Seasonal Pattern Assessment Questionnaire (SPAQ) (Magnusson, 2000). Studies using clinical interview or the more diagnostically valid Seasonal Health Questionnaire consistently report lower estimates with rates around 2–5% for central European countries (Pjrek et al., 2016; Thompson et al., 2004). Light treatment (first choice treatment), psychotherapy and antidepressant medication are effective treatments (Golden et al., 2005; Rohan et al., 2009, 2016) but the intertwining neurobiological, cognitive and environmental factors leading to the condition remain unclear.

    • Epidemiology and socioeconomic impact of seasonal affective disorder in Austria

      2016, European Psychiatry
      Citation Excerpt :

      During the interview we employed telephone versions of the three following psychometric instruments: the Seasonal Health Questionnaire (SHQ) [28,29] was used to establish a diagnosis of major depressive disorder (MDD) and of SAD according to DSM-5. The SHQ has a positive predictive value of 0.929 and a negative predictive value of 0.786 for diagnosis of SAD during the past 10 years [29].

    • Frequency and characteristics of individuals with seasonal pattern among depressive patients attending primary care in France

      2015, General Hospital Psychiatry
      Citation Excerpt :

      Two recent studies [3,4] conducted in university-affiliated psychiatric departments have found a higher prevalence in BD and particularly in the BD II subtype. Three studies conducted in England [5–7] that used other criteria than the DSM-IV ones to define SP have found that it was not uncommon in primary care settings. A previous survey conducted in patients consulting general practitioners (GPs) in France showed a high screen positive rate for BD in patients attending primary care [8].

    • Seasonal affective disorder, grief reaction, and adjustment disorder

      2014, Medical Clinics of North America
      Citation Excerpt :

      The higher measure was based on the SPAQ, which may have overestimated the incidence. Using the SHQ, approximately 5% of patients in primary care practices have SAD.6 The disorder is more common in women and tends to affect younger adults.

    View all citing articles on Scopus
    View full text